Indian shares gave up early gains to edge lower on Monday as investors kept an eye on rising coronavirus cases in the country and awaited more large-cap earnings for directional cues.
The benchmark S&P BSE Sensex dropped 174 points, or 0.46 percent, to 37,954 in early trade, while the broader NSE Nifty index was down 55 points, or 0.49 percent, at 11,139.
Biocon lost 2.4 percent on news that the firm's itolizumab drug has not been included in national treatment protocol for Covid-19 patient.
Lupin fell nearly 2 percent and Granules India slumped 4.3 percent after announcing a product recall in the U.S.
ICICI Bank tumbled 3.6 percent after its quarterly profit missed estimates.
Kotak Mahindra Bank rose 1.3 percent while Tech Mahindra slid half a percent ahead of their earnings later in the day.
HDFC Bank declined 2.6 percent after its chief executive and managing director Aditya Puri sold more than 7.4 million shares of the private lender to raise Rs 842.87 crore.
원저자가 모두 저작권을 보유한 RTTNews에서 재 인쇄 함.
면책 조항: 본 게시글에 표현된 견해는 전적으로 작성자의 견해이며 Followme의 공식 입장을 대변하지 않습니다. Followme는 제공된 정보의 정확성, 완전성 또는 신뢰성에 대해 책임을 지지 않으며, 서면으로 명시적으로 언급되지 않는 한 해당 내용을 기반으로 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다.
더 오래된 의견은 없습니다. 소파를 가장 먼저 잡으십시오.